成人隐匿性自身免疫糖尿病(LADA)的诊断目前主要依靠临床特点结合检测患者血清中的抗体,常用的血清学抗体包括谷氨酸脱羧酶自身抗体(GADA)、胰岛细胞抗体(ICA)、蛋白酪氨酸磷酸酶抗体(IA-2A)、锌转运体-8自身抗体(ZnT8A)和羧基肽酶-H抗体(CPH-Ab),明确这些抗体的诊断意义对LADA预测、诊断和预后评估均有价值。

[1] 中华医学会糖尿病学分会.中华医学会糖尿病学分会关于成人隐匿性自身免疫糖尿病(LADA)诊疗的共识[J].中华糖尿病杂志,2012,4(11):641-647.
[2] ZHOU Z,XIANG Y,JI L,et al.Frequency,immunogenetics,and clinical characteristics of latent autoimmune diabetes in China(LADA in China):a nationwide,multicenter,clinic-based cross-sectional study[J].Diabtes,2013,62(2):543-550.
[3] LUNDGREN V M,ISOMAA B,LYSSENKO V,et al.GAD antibody positivity predicts type 2 diabetes in an adult population[J].Diabetes,2010,59(2):416-422.
[4] BAEKKESKOV S,AANSTOOT H J,CHRISGAU S,et al.Identification of the 64k autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase[J].Nature,1990,347(6289):151-156.
[5] NAIK R G,BROOKS-WORRELL B M,PALMER J P.Latent autoimmune diabetes in adult[J].J Clin Endocrinol Metab,2009,94:4635-4644.
[6] HAWA M I,BUCHAN A P,OLA T,et al.LADA and CARDS:A prospective study of clinical outcome in established adult-onset autoimmune diabetes [J].Diabetes Care,2014,37:1643-1649.
[7] ZAMPETTI S,CAMPAGNA G,TIBERTI C,et al.High GADA titer increases the risk of insulin requirement in LADA patients:a 7-year follow-up (NIRAD study 7)[J].Eur J Endocrinol,2014,171(6):697-704.
[8] CERNEA S,BUZZETTI R,POZZILLI P.β-cell protection and therapy for latent autoimmune diabetes in adults[J].Diabetes Care,2009,32(Suppl 2):S246-S252.
[9] 李霞,周智广,黄干,等.谷氨酸脱羧酶(GAD65)抗体水平对成人隐匿性自身免疫糖尿病两种亚型的识别[J].中华内科杂志,2003,42(1):7-10.
[10] MAIOLI M,PES G M,DELITALA G,et al.Number of autoantibodies and HLA genotype,more than high titers of glutamic acid decarboxylase autoantibodies,predict insulin dependence in latent autoimmune diabetes of adults[J].Eur J Endocrinol,2010,163(4):541-549.
[11] YANG Z,ZHOU Z,LI X,et al.Rosiglitazone preserves islet β-cell function of adult-onset latent autoimmune diabetes in 3 years follow-up study[J].Diabetes Res Clin Pract,2009,83(1):54-60.
[12] 毕永春,胡伟,张葵.2型糖尿病患者血清中4种胰岛自身抗体检测的临床意义[J].现代医学,2011,39(6),647-649.
[13] BOTTAZZO G F,BOSI E,CULL C A,et al.IA-2 antibody prevalence and risk assessment of early insulin requirement in subjects presenting with type 2 diabetes (UKPDS71)[J].Diabetologia,2005,48(4):703-708.
[14] MAIOLI M,PES G M,DELITALA G,et al.Number of autoantibodies and HLA genotype,more than high titers of glutamic acid decarboxylase autoantibodies,predict insulin dependence in latent autoimmune diabetes of adults[J].Eur J Endocrinol,2010,163(4):541-549.
[15] BLASLOV K,BULUM T,KNEEVIĆ-ĆUĆA J,et al.Relationship between autoantibodies combination,metabolic syndrome components and diabetic complications in autoimmune diabetes in adults[J].Endocrine,2015,48(2):551-556.
[16] WENZLAU J M,JUHL K,YU L,et al.The cation efflux transporter ZnT8 (Slc30A8) is amajor autoantigen in human type 1 diabetes[J].Proc Natl Acad Sci U S A,2007,104(43):17040-17045.
[17] RUTTER G A.Think zinc:new roles for zinc in the control of insulin secretion[J].Islets,2010,2(1):49-50.
[18] ANDERSSON C,LARSSON K,VAZIRI-SANI F,et al.The three ZNT8 autoantibody variants together improve the diagnostic sensitivity of childhood and adolescent type 1 diabetes[J].Autoimmunity,2011,4(5):394-405.
[19] HUANG G,XIANG Y.Zinc transporter 8 autoantibody(ZnT8A) could help differentiate latent autoimmune diabetes in adults(LADA) from phenotypic type 2 diabetes mellitus[J].Diabetes Metab Res Rev,2013,29(5):363-368.
[20] YANG L,LUO S,HUANG G,et al.The diagnostic value of zinc transporter 8 autoantibody (ZnT8A) for type 1 diabetes in Chinese[J].Diabetes Metab Res Rev,2010,26(7):579-584.
[21] TRABUCCHI A,FACCINETTI N I,GUERRA L L,et al.Detection and characterization ofZnT8 autoantibodies could help to screen latent autoimmune diabetes in adult-onset patients with type 2 phenotype[J].Autoimmunity,2012,45(2):137-142.
[22] HUTTON J C.The insulin secretory granule[J].Diabetologia,1989,32(5):271-281.
[23] CASTANO L,RUSSO E,ZHOU L,et al.Identification and cloning of a granule autoantigen Carboxypeptidase-H associated with type 1 diabetes[J].J Clin Endocrinol Metab,1991,73(6):1197-1201.
[24] 杨琳,周智广,黄干,等.羧基肽酶H抗体对成人隐匿性自身免疫糖尿病的诊断意义[J].中国糖尿病杂志,2003,11(1):20-25.
[25] 杨琳,周智广,黄干,等.四种胰岛自身抗体诊断成人隐匿性自身免疫性糖尿病的临床意义[J].中华内分泌代谢杂志,2005,21(4):327-330.
[26] 杨琳,周智广,杜弢,等.ELISPOT检测羧基肽酶H阳性成人隐匿性自身免疫性糖尿病患者羧基肽酶H反应性T细胞[J].中南大学学报:医学版,2009,34(10):1006-1011.